Related Experiment Video
Updated: May 27, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Genotoxic risks in patients with COVID-19
Nurşen Başaran1, Olga Szewczyk-Roszczenko2, Piotr Roszczenko3
1Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Başkent University, Ankara 06790, Türkiye.
Abstract:
The COVID-19 pandemic has caused numerous deaths worldwide. Despite the mitigation of infection manifestations in recent months, the possible consequences of the epidemic remain difficult to predict. Genotoxicity and subsequent development of neoplasms are possible outcomes. This review summarises the data on these questions. Studies from several countries have reported increased levels of DNA damage in nucleated blood cells of patients with severe forms of COVID-19 infection. The level of DNA damage can be used as a prognostic factor for the disease outcome. It is considered that SARS-CoV-2 spike proteins play a crucial role in DNA damage; however, the virus also inhibits the DNA repair system. Co-morbidities and use of antiviral drugs may also contribute to DNA damage in patients with COVID-19.
Related Concept Videos
Mutagenicity and Carcinogenicity
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs
Teratogenicity
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

